Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Enhanced Neuroprotective Effects of Combination Therapy with Bone Marrow-Derived Mesenchymal Stem Cells and Ginkgo biloba Extract (EGb761) in a Rat Model of Experimental Autoimmune Encephalomyelitis.
Role of TNF in mast cell neuroinflammation and pain.
Tract-specific quantitative MRI better correlates with disability than conventional MRI in multiple sclerosis.
Use of the PRIMUS scale to assess quality of life in a Spanish population of multiple sclerosis patients.
Acid-sensing ion channels in pathological conditions.
Early treatment with high-dose interferon beta-1areverses cognitive and cortical plasticity deficits in multiple sclerosis.
Recommendations for the Use of Prolonged-Release Fampridine in Patients with Multiple Sclerosis (MS).
Endovascular diagnosis and management of chronic cerebrospinal venous insufficiency: retrospective analysis of 30-day morbidity and mortality in 95 consecutive patients.
Therapeutic decision making in a new drug era in multiple sclerosis.
Novel insights into the development and maintenance of the blood-brain barrier.
Long-term benefits of induction therapy in NMO: a case report.
An epidemiological study of neuromyelitis optica in Isfahan.
Corneal Sensitivity and Tear Function in Neurodegenerative Diseases.
Identification of a microglia phenotype supportive of remyelination.
The squares test as a measure of hand function in multiple sclerosis.
Central nervous system inflammatory demyelinating disorders among Hong Kong Chinese.
[Impact of physical activity level on alexithymia and coping strategies in an over-40 multiple sclerosis population: A pilot study.]
Off-pump coronary surgery in a patient with multiple sclerosis.
Natural killer cells in human autoimmune disorders.
T-cell homeostasis in pediatric multiple sclerosis: Old cells in young patients.
On the estimation and correction of bias in local atrophy estimations using example atrophy simulations.
Transglutaminase 2 and neuroinflammation.
Modeling the Relationship among Gray Matter Atrophy, Abnormalities in Connecting White Matter, and Cognitive Performance in Early Multiple Sclerosis.
Sativex-induced neurobehavioral effects: causal or concausal? A practical advice!
Decrease in newly generated oligodendrocytes leads to motor dysfunctions and changed myelin structures that can be rescued by transplanted cells.
Pages
« first
‹ previous
…
360
361
362
363
364
365
366
367
368
…
next ›
last »